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Genome-guided Screening of Bacterial Isolates 
to Identify Potential Antibiotic Producers.
Opeyemi K. Awolope, Noelle H. O’Driscoll, and Andrew J. Lamb. 
 o.k.awolope@rgu.ac.uk
A topsoil sample was collected from the rhizosphere 
approximately 3cm beneath the soil surface.
Bacterial strains were isolated on ultra minimal 
substrate media (1:100 Ravan Media). Four 
representative colonies with different 
morphological characteristics were selected and 
purified.
Isolates were cultivated on various solid and liquid 
media with different nutrient levels and at different 
incubation temperatures to establish nutritional 
versatility. 
Genomic DNA was extracted from isolates, 
followed by 16S rRNA gene amplification in 
PCR reactions
➢ Multidrug resistant infections could reduce global economic output by $100 trillion
by 2050.1 Therefore, the need for new antibiotics cannot be overemphasized.
➢ Bacterial secondary metabolites remain a relatively untapped source of new
therapies. However, the ability to produce these compounds is not universal.
➢ Key attributes of producing strains include a large genome (>3Mb), and the presence
of antibiotic-encoding biosynthetic gene clusters (BGCs) within the genome.2 These
attributes are largely determined by phylogeny.
➢ Some antibiotic producers also possess the ability to withstand nutritional stress.3
➢ Here we use these attributes to identify potential antibiotic producers.
Background:
Amplified DNA fragments were sequenced using Applied 
BioSystem Big-Dye technology
16S rRNA gene sequence data was analysed by CHROMAS 
and entered into BLAST for comparison. Identity
was set at ≥99% sequence alignment.
The antiSMASH database4 was browsed by phylogeny to locate identified 
genera. The BGC distribution in these genera were noted. The typical 
genome size associated with species within the genera were obtained 
from literature and the NCBI database.
➢ Use ultra minimal substrate media to isolate nutritionally versatile bacterial strains
from nutrient-rich soil sample collected from the rhizosphere.
➢ Identify isolates by 16S rRNA gene sequence comparison.
➢ Use genomic data i.e. typical genome size and BGC distribution, to identify potential
antibiotic producers.
➢ Obtain whole genome sequence data of potential antibiotic-producing strains.
➢ Scan genomes for antibiotic-encoding BGCs, and prioritise novel, silent or cryptic
genes for in silico analyses to predict optimal fermentation conditions for gene
expression.
Objectives:
Results:
➢ Whole genome sequence data will be obtained for all four isolates. 
➢ The data will be submitted to the antiSMASH database for identification, annotation 
and analysis of potential antibiotic-encoding BGCs.
➢ Novel, cryptic or silent BGCs will be prioritised for in silico analysis to predict 
favourable fermentation conditions, and chemical structures of compounds of 
interest.
➢ Metabolic profiling of fermentation broths will be carried out using suitable 
analytical techniques.
➢ Novel compounds with properties consistent with those of antibiotics i.e. low 
molecular weight, low lipophilicity, and carrying a net charged, will be selected for 
further bioactivity assays.
Future work plan:
➢ Nutritionally versatile bacterial strains have been recovered by the isolation protocol 
described here.
➢ To date isolates analysed belong to genera of secondary metabolite producers. The 
Pseudomonas sp. may have the largest genome with more antibiotic-encoding BGCs 
compared to other isolates, making it the most promising strain for genome mining.
➢ The potentials of the Hafnia and the Obesumbacterium sp. as secondary metabolite 
producers may be understated given the typical genome size associated with these 
species. These isolates are also expected to be antibiotic producers given their 
ecological origin. They are therefore also suitable for genome mining. 
➢ The genome-guided screening exercise described here is being explored as a tool to 
facilitate and expedite rational drug discovery initiatives.
Conclusions:
Methods:
Pseudomonas Hafnia Obesumbacterium
Typical genome size of 
species (Mb) 6.2 4.7 5.0
No of listed strains 
(antiSMASH DB) 1,236 14 1
Average no of BGCs 
per strain 11 3 2
Average no of 
antibiotic-encoding 
BGCs
7 2 0
Pseudomonas Hafnia Obesumbacterium
Hybrid
Polyketide
Thiopeptide
Lanthipeptide
Phenazine
Bacteriocins
Nonribosomal Peptides
➢ Up to 65 distinct colonies were recovered on ultra minimal substrate
media as described above.
➢ Initially, four representative colony types (i.e. different morphological
characteristics) were selected for purification.
➢ All four isolates were found to be nutritionally versatile.
➢ Isolates were identified as Pseudomonas (1), Hafnia (2) and Obesumbacterium (1)
species.
➢ BGC distribution in these species, and typical genome size are outlined in Table 1.
➢ Figure 1 shows the classes of secondary metabolites with antibiotic properties that
could be encoded by BGCs in these species.
Table 1: BGC distribution and typical genome size of species
in identified  genera.
Figure 1: Classes of secondary metabolites with antibiotic properties encoded
by BGCs in identified species.
